amitriptyline has been researched along with Cachexia in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grewal, J | 1 |
| Bril, V | 1 |
| Lewis, GF | 1 |
| Lewis, G | 1 |
| Perkins, BA | 1 |
| Gade, GN | 1 |
| Hofeldt, FD | 1 |
| Treece, GL | 1 |
2 other studies available for amitriptyline and Cachexia
| Article | Year |
|---|---|
Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia.
Topics: Adult; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cachexia; Cyclohexanecar | 2006 |
Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine.
Topics: Amitriptyline; Cachexia; Diabetic Neuropathies; Drug Therapy, Combination; Fluphenazine; Humans; Syn | 1980 |